Stevanato Group (NYSE:STVN) Given New $26.00 Price Target at Citigroup

Stevanato Group (NYSE:STVN) had its price objective lowered by Citigroup from $32.00 to $26.00 in a research report released on Thursday,Benzinga reports. Citigroup currently has a buy rating on the stock.

STVN has been the subject of several other reports. KeyCorp decreased their target price on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday. Weiss Ratings reissued a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. Morgan Stanley began coverage on shares of Stevanato Group in a research note on Monday, December 1st. They set an “equal weight” rating and a $24.00 target price for the company. Wall Street Zen lowered shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Finally, Jefferies Financial Group set a $17.50 target price on Stevanato Group in a research report on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

Stevanato Group Stock Performance

Stevanato Group stock opened at €15.98 on Thursday. The company has a market cap of $4.84 billion, a PE ratio of 27.55, a price-to-earnings-growth ratio of 1.44 and a beta of 0.57. Stevanato Group has a twelve month low of €13.91 and a twelve month high of €28.00. The company’s 50-day moving average price is €17.69 and its 200-day moving average price is €21.71. The company has a quick ratio of 1.30, a current ratio of 1.89 and a debt-to-equity ratio of 0.26.

Institutional Trading of Stevanato Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Pembroke Management LTD grew its holdings in shares of Stevanato Group by 11.9% in the third quarter. Pembroke Management LTD now owns 1,283,216 shares of the company’s stock valued at $33,043,000 after purchasing an additional 136,710 shares during the period. Cooper Investors PTY Ltd. boosted its holdings in Stevanato Group by 251.7% in the 3rd quarter. Cooper Investors PTY Ltd. now owns 590,308 shares of the company’s stock valued at $15,200,000 after purchasing an additional 422,478 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of Stevanato Group by 7.1% in the 3rd quarter. Thrivent Financial for Lutherans now owns 2,372,390 shares of the company’s stock valued at $61,089,000 after buying an additional 156,733 shares during the period. Ranger Investment Management L.P. increased its holdings in shares of Stevanato Group by 125.6% during the 2nd quarter. Ranger Investment Management L.P. now owns 1,321,030 shares of the company’s stock worth $32,273,000 after buying an additional 735,417 shares during the last quarter. Finally, Artisan Partners Limited Partnership increased its holdings in shares of Stevanato Group by 20.0% during the 2nd quarter. Artisan Partners Limited Partnership now owns 2,733,782 shares of the company’s stock worth $66,786,000 after buying an additional 455,323 shares during the last quarter.

Key Stories Impacting Stevanato Group

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Q4 results showed revenue growth and an EPS beat (roughly €0.21 vs. ~€0.20 expected), with quarterly revenue of €346.5m and expanded margins — news that initially supported upside in the stock. Stevanato Group SpA (STVN) Q4 2025 Earnings Call Highlights
• Positive Sentiment: Full‑year 2025: revenue +7% (9% at constant currency) and record revenue from higher‑value solutions, evidence of continued product mix improvement and margin leverage. Stevanato Group Delivers 7% Revenue Growth for Fiscal Year 2025
• Positive Sentiment: The company outlined a 2026 revenue target (up to ~€1.308B) and expects high‑value solutions to reach roughly 48% of sales — a strategic growth driver that supports longer‑term earnings potential. Stevanato Group outlines 2026 revenue target up to €1.308B
• Neutral Sentiment: Management issued FY‑2026 EPS guidance of €0.690–0.730 (consensus ~0.730) and revenue guidance roughly in line with street expectations — guidance is cautious and offsets some of the positive beats. Stevanato FY‑2026 Guidance (slide deck/press release)
• Neutral Sentiment: Full Q4 / FY call transcripts and coverage are available for more detail on backlog, mix and capex — useful for assessing sustainability of the high‑value mix shift. Q4 2025 Earnings Call Transcript
• Negative Sentiment: Two analyst price‑target cuts arrived: KeyCorp trimmed its PT to $32 (from $37; overweight) and Citigroup cut its PT to $26 (from $32; buy). These downgrades likely pressured the stock despite positive results. KeyBanc PT Lowered to $32 Citigroup PT Cut (Benzinga)
• Negative Sentiment: Market technicals and price action are weak: the stock is trading below its 50‑ and 200‑day moving averages and volume was higher than average, consistent with a selling reaction after the mixed guidance/analyst actions. Market data and technicals (MarketBeat)

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.